LTFU - FAQ's - Graft-vs.-Host-Disease FAQs — Graftvs.-Host-Disease. What is the risk for developing chronic graft-vs.-host disease (GVHD) after transplant? What would indicate a need for systemic treatment of http://www.fhcrc.org/science/clinical/ltfu/faqs/gvhd.html
Extractions: @import "../../../../wrapper/global.css"; @import "../../../../wrapper/wrapper.css"; Q. What is the risk for developing chronic graft-vs.-host disease (GVHD) after transplant? About 60 percent of patients who receive an allogeneic transplant and are alive at day 100 will develop chronic GVHD. Q. What would indicate a need for systemic treatment of chronic GVHD? Systemic immunosuppressive treatment with a medication like prednisone is not usually necessary for patients who have mild chronic GVHD. For example, someone with a platelet count greater than 100,000 and mild symptoms in just one site, such as the mouth, would probably not require systemic treatment. Someone with chronic GVHD involving multiple sites such as liver and skin or eyes and genital tract, or someone with chronic GVHD and a platelet count less than 100,000 would require systemic therapy. If symptoms are severe, systemic immunosuppressive treatment may be needed even when only a single site is involved. Your doctor, can determine if you need systemic treatment. The LTFU is available to help your doctor in making this decision.
The SCID Homepage Graft Vs. Host Disease Graftvs-host disease (GvHD) is a complication that is observed after allogeneic stem cell / bone marrow http://www.scid.net/ivig.htm
IBMT: FAQ - Graft-Versus-Host Disease GraftVersus-Host Disease What Is Graft-Versus-Host Disease? Patients who receive a stem cell transplant from an identical twin donor, are infused with stem cells that are truly http://www.ibmtindy.com/faq/graft.htm
Extractions: Patients A "reversed rejection" can also occur. Under this scenario, the healthy donor stem cells recognize the patient's tissues as foreign and attack them. This is the "transplant against the patient", or "Graft-versus-Host" reaction. The complication is called "Graft-versus-Host Disease" (GvHD). Commonly, GvHD is divided into acute GvHD and chronic GvHD. Acute GvHD occurs within the first 100 days after transplant, but most often between 25 and 60 days after stem cell infusion. Chronic GvHD occurs beyond day 100 after transplant. Acute GvHD can lead to chronic GvHD, but chronic GvHD may occur without any evidence of previous acute GvHD. The chronic variant of GvHD may occur up to several years after transplant, indicating that the "fight" between donor stem cells and patient tissues can continue for years. In fact, at some level the fight between donor and recipient will never stop. The donor stem cells will never feel completely at home. In patients receiving a graft from an HLA-identical sibling, ultimately the donor stem cells will function quite normally. Patients who received grafts from HLA-mismatched donors will remain at an increased risk of infections for many years. What Are The Symptoms Of Acute GvHD?
Graft-vs-Host Disease In order for our site to display correctly you will need a newer version of your web browser. The following browsers support numerous web standards including CSS,XHTML, and the http://www.stjude.org/stjude/v/index.jsp?vgnextoid=f32ffa2454e70110VgnVCM1000001
GVHD (Graft-Versus-Host Disease) Patient Information Publications Clinical Center National Institutes of Health GVHD (GraftVersus-Host Disease) A Guide for Patients and Families After Stem Cell Transplant The immune http://www.cc.nih.gov/ccc/patient_education/pepubs/gvh.pdf
Extractions: From Wikipedia, the free encyclopedia Jump to: navigation search Transfusion-associated graft versus host disease Classification and external resources ICD T ICD Transfusion-associated graft versus host disease (TA-GvHD) is a rare complication of blood transfusion , in which the donor T lymphocytes mount an immune response against the recipient's lymphoid tissue. Donor lymphocytes are usually identified as foreign and destroyed by the recipient's immune system. However, in situations where the recipient is immunocompromised (inborn immunodeficiency , acquired immunodeficiency, malignancy ), or when the donor is homozygous and the recipient is heterozygous for an HLA haplotype (as can occur in directed donations from first-degree relatives), the recipient's immune system is not able to destroy the donor lymphocytes. This can result in graft versus host disease The incidence in immunocompromised patients receiving blood transfusions is estimated to be 0.1 - 1.0%, mortality around 80 - 90%. Mortality is higher in TA-GvHD than in GvHD associated with
Graft-vs.-Host Disease Information On Healthline Graftvs.-host disease is a response by the immune system that occurs when cells from a blood or bone marrow donor attack those of the recipient. http://www.healthline.com/galecontent/graft-vs-host-disease
Extractions: You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better. Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Neurology and Psychiatry (1919-1959) Ophthalmology Surgery Calendar of Events JAMA Career Center For The Media JAMAevidence AMA Manual of Style Peer Review Congress ABOUT ARCHIVES Search: Advanced Search Welcome My Account E-mail Alerts Sign In Information for: Authors/Reviewers Readers Institutions/Libraries Subscription Agents News Media Job Seekers/Employers Advertisers Vol. 123 No. 6, June 1987 Online Only Online First Table of
Graft-Versus-Host Disease - Symptoms, Diagnosis, Treatment Of Graft-Versus-Host Free articles and multimedia from The NY Times, including information on symptoms, diagnosis, treatments, tests, and surgical procedures, as well as current news and interviews http://health.nytimes.com/health/guides/disease/graft-versus-host-disease/overvi
Graft Vs Host Disease - A Comprehensive View - Wellsphere Find out all about Graft versus host disease, including the most common causes, symptoms and treatments from leading medical experts. http://www.wellsphere.com/wellpage/graft-vs-host-disease
Extractions: Health knowledge made personal Home Communities WellPages Resources Near You ... Log in Narrow by: Causes of Graft versus host disease Symptoms of Graft versus host disease Treatments for Graft versus host disease Tests for Graft versus host disease ... Alternative Treatments for Graft versus host disease Related WellPages: Bone marrow transplantation Cyclosporin Immunosuppressive Leukemia ... Resources Near You Find heart valve replacement options Ask About Health Mavens Lupus More WellPages: does appetite suppressants work does aspire weight loss pills work does b total sublingual liquid help with weight loss does b vitamin make you lose weight ... does being overweight cause back pain Lisa R. Detroit, Michigan Lisa Robertson is a freelance writer specializing in health. She works at providing information... More Vanessa M. Silver Spring, Maryland Vanessa Maltin received a bachelor's degree in journalism from the George Washington...
ApexMD : Specialist Doctors Who Treat 'graft Vs Host Disease' Definition The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the http://search.apexmd.com/search.aspx?q=Graft vs Host Disease
Graft-vs-Host Disease | Doctor | Patient UK Graftvs-Host Disease - The number of allogeneic bone marrow and stem cell transplants is increasing worldwide. Yet as our knowledge of immunosuppr http://www.patient.co.uk/doctor/Graft-vs-Host-Disease.htm
Extractions: Click here to return to the home page Click here to read our 'About Us' page About Us You are here: Home PatientPlus Graft-vs-Host Disease Click here to open a printer-friendly version of this document, in a new window, together with the print dialogue box Click here to open this document in PDF format Note: this is the best way to print the document Click here to listen to the MP3 audio recording of this document Click here to download the audio recording of this document as a podcast, for listening to at your leisure Click here to open our Dictionaries and Glossaries page Click here to see related products in our Online Pharmacy
Graft Vs Host Disease - Hutchinson Encyclopedia Article About Complication of bonemarrow transplant where the grafted bone marrow attacks its host. In its mildest form patients develop a skin rash, but gut and liver inflammation can http://encyclopedia.farlex.com/Graft vs host disease
Graft-vs.-Host Disease: Encyclopedia Of Cancer . Graftvs.-host disease is a response by the immune system that occurs when cells from a blood or bone marrow donor attack those of the recipient. http://www.enotes.com/cancer-encyclopedia/graft-vs-host-disease
Autologous Graft Vs. Host Disease Symptoms | EHow.com Autologous Graft Vs. Host Disease Symptoms. Autologous grafts involve using a person's tissue to replace tissue that is diseased or not functioning properly in his own body. http://www.ehow.com/facts_5939169_autologous-vs_-host-disease-symptoms.html
Extractions: Home Health Immune System Disorders ... Autologous Graft Vs. Host Disease Symptoms By Ngozi Oguejiofo eHow Contributor updated: February 1, 2010 I want to do this! What's This? Autologous grafts involve using a person's tissue to replace tissue that is diseased or not functioning properly in his own body. Autologous graft vs. host disease occurs when a person's immune system attacks and destroys transplanted tissue acquired from his own body. A person with autologous graft versus host disease may develop red, itchy rashes in some parts of his body like this face, the palms of his hands and the soles of his feet. The gastrointestinal system may be affected in a case of autologous graft versus host disease with the following signs: diarrhea, abdominal pain, abdominal cramps, nausea and loss of appetite